Figg WD - Search Results

1

Chau CH, Steeg PS, Figg WD. Chau CH, et al. Among authors: figg wd. Lancet. 2019 Aug 31;394(10200):793-804. doi: 10.1016/S0140-6736(19)31774-X. Lancet. 2019. PMID: 31478503 Review.

2

Thalidomide.

Franks ME, Macpherson GR, Figg WD. Franks ME, et al. Among authors: figg wd. Lancet. 2004 May 29;363(9423):1802-11. doi: 10.1016/S0140-6736(04)16308-3. Lancet. 2004. PMID: 15172781 Review.

3

Molecular and phenotypic heterogeneity of metastatic prostate cancer.

Chau CH, Figg WD. Chau CH, et al. Among authors: figg wd. Cancer Biol Ther. 2005 Feb;4(2):166-7. doi: 10.4161/cbt.4.2.1571. Epub 2005 Feb 28. Cancer Biol Ther. 2005. PMID: 15738648 Review.

4

Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.

Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS. Palmieri D, et al. Among authors: figg wd. J Natl Cancer Inst. 2005 May 4;97(9):632-42. doi: 10.1093/jnci/dji111. J Natl Cancer Inst. 2005. PMID: 15870434

5

Modulation of cytochrome P450 activity: implications for cancer therapy.

Scripture CD, Sparreboom A, Figg WD. Scripture CD, et al. Among authors: figg wd. Lancet Oncol. 2005 Oct;6(10):780-9. doi: 10.1016/S1470-2045(05)70388-0. Lancet Oncol. 2005. PMID: 16198984 Review.

6

Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.

Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK, Figg WD. Chau CH, et al. Among authors: figg wd. Cancer Biol Ther. 2005 Nov;4(11):1222-5. doi: 10.4161/cbt.4.11.2091. Epub 2005 Nov 11. Cancer Biol Ther. 2005. PMID: 16205110

7

Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer.

Singh AS, Chau CH, Price DK, Figg WD. Singh AS, et al. Among authors: figg wd. Nat Clin Pract Urol. 2005 Feb;2(2):101-7. doi: 10.1038/ncpuro0091. Nat Clin Pract Urol. 2005. PMID: 16474655 Review.

8

Heterogeneity in drug disposition determines interindividual variability of docetaxel pharmacokinetics.

Figg WD, Chau CH. Figg WD, et al. Cancer Biol Ther. 2006 Jul;5(7):840-1. doi: 10.4161/cbt.5.7.3025. Epub 2006 Jul 12. Cancer Biol Ther. 2006. PMID: 16880730 No abstract available.

9

Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.

Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA. Gills JJ, et al. Among authors: figg wd. Clin Cancer Res. 2007 Sep 1;13(17):5183-94. doi: 10.1158/1078-0432.CCR-07-0161. Clin Cancer Res. 2007. PMID: 17785575

10

Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.

Hamada A, Danesi R, Price DK, Sissung T, Chau C, Venzon D, Sparreboom A, Dahut WL, Figg WD. Hamada A, et al. Among authors: figg wd. Urology. 2007 Aug;70(2):217-20. doi: 10.1016/j.urology.2007.06.1097. Urology. 2007. PMID: 17826473 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

774 results

Search Page